Reply to: Postoperative Unstimulated Thyroglobulin for the Decision to Use Radioactive Iodine in Patients with Low- or Intermediate-Risk Papillary Thyroid Carcinoma.
作者信息
McDow Alexandria D
机构信息
Section of Endocrine Surgery, Division of Surgical Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.
出版信息
Ann Surg Oncol. 2019 Dec;26(Suppl 3):869-870. doi: 10.1245/s10434-019-07724-x. Epub 2019 Aug 28.
PMID:31463692
Abstract
摘要
相似文献
1
Reply to: Postoperative Unstimulated Thyroglobulin for the Decision to Use Radioactive Iodine in Patients with Low- or Intermediate-Risk Papillary Thyroid Carcinoma.回复：低危或中危乳头状甲状腺癌患者使用放射性碘决策中的术后未刺激甲状腺球蛋白
Ann Surg Oncol. 2019 Dec;26(Suppl 3):869-870. doi: 10.1245/s10434-019-07724-x. Epub 2019 Aug 28.
2
Postoperative Unstimulated Thyroglobulin for the Decision to Use Radioactive Iodine in Patients with Low- or Intermediate-Risk Papillary Thyroid Carcinoma.术后未刺激甲状腺球蛋白用于低危或中危乳头状甲状腺癌患者放射性碘使用决策
Ann Surg Oncol. 2019 Dec;26(Suppl 3):867-868. doi: 10.1245/s10434-019-07722-z. Epub 2019 Aug 12.
3
Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?低危和中危甲状腺乳头状癌患者甲状腺全切除术后不可检测到甲状腺球蛋白——是否需要放射性碘治疗？
Surgery. 2012 Dec;152(6):1096-105. doi: 10.1016/j.surg.2012.08.034.
4
Serial post-surgical stimulated and unstimulated highly sensitive thyroglobulin measurements in low- and intermediate-risk papillary thyroid carcinoma patients not receiving radioactive iodine.在未接受放射性碘治疗的低风险和中风险甲状腺乳头状癌患者中，进行术后系列刺激和非刺激状态下的高敏甲状腺球蛋白测量。
Endocrine. 2016 Nov;54(2):460-466. doi: 10.1007/s12020-016-0989-3. Epub 2016 May 17.
5
Effect of postoperative 131I treatment on thyroglobulin measurements in the follow-up of patients with thyroid cancer.术后¹³¹I治疗对甲状腺癌患者随访中甲状腺球蛋白测量值的影响。
Thyroid. 1994 Fall;4(3):239-42. doi: 10.1089/thy.1994.4.239.
6
Serum thyroglobulin in patients with early thyroid cancer who have residual thyroid after total thyroidectomy.
Lancet. 1984 Feb 18;1(8373):398. doi: 10.1016/s0140-6736(84)90452-5.
7
Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.述评：术后刺激甲状腺球蛋白在低危甲状腺乳头状癌放射性碘残留消融选择中的应用
Head Neck. 2010 Jun;32(6):698-9. doi: 10.1002/hed.21375.
8
Thyroglobulin-guided (131)I ablation in low-risk differentiated thyroid carcinoma: is the yardstick accurate enough?低危分化型甲状腺癌中甲状腺球蛋白引导下的（131）I消融：这一标准足够准确吗？
Head Neck. 2011 Sep;33(9):1379-80; author reply 1380-1. doi: 10.1002/hed.21788. Epub 2011 Jul 7.
9
The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.对于cN0期甲状腺乳头状癌患者，在术后甲状腺球蛋白随访方面，预防性中央淋巴结清扫的必要性存在争议。
Langenbecks Arch Surg. 2017 Mar;402(2):235-242. doi: 10.1007/s00423-017-1556-y. Epub 2017 Feb 21.
10
Postoperative stimulated thyroglobulin of less than 1 ng/ml as a criterion to spare low-risk patients with papillary thyroid cancer from radioactive iodine ablation.将术后刺激甲状腺球蛋白水平控制在 1ng/ml 以下作为一种标准，以避免放射性碘消融治疗低危型甲状腺乳头状癌患者。
Thyroid. 2012 Nov;22(11):1140-3. doi: 10.1089/thy.2012.0190. Epub 2012 Oct 10.
Zotero 插件